Immunoproteasome activator 1
Immunoproteasome activator 1 (compound A) is a selective immunoproteasome activator that increases the presentation of individual MHC-I–bound peptides by over 100-fold. Immunoproteasome activator 1 binds to the proteasome structural subunit PSMA1 and promotes the association of the proteasome activator PA28α/β (PSME1/PSME2) with immunoproteasomes[1].
Product Specifications
CAS Number
901728-48-1
UNSPSC
12352211
Target
Proteasome
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/immunoproteasome-activator-1.html
Purity
90.0
Smiles
O=C(C)C1=CC(NC(C2=CC3=C(C(CCCN4CCC5)=C4C5=C3)OC2=N)=O)=CC=C1
Molecular Formula
C24H23N3O3
Molecular Weight
401.46
References & Citations
[1]Rana PS, et al. Immunoproteasome activation expands the MHC class I immunopeptidome, unmasks neoantigens and enhances T-cell antimyeloma activity. Mol Cancer Ther. 2024 Aug 30.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC471844-100 1x 100 µL
CD79b (B-Cell Marker) (IGB/1844), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details